Matthew Hayes

Nov 27, 2024 | seekingalpha.com | Matthew Hayes

Nov. 27, 2024 1:59 AM ET, SummaryKits Eyecare is experiencing organic revenue growth of over 20% YOY selling glasses & contacts over its digital platform Kits.com. In 2021, Kits built a best-in-class optical lab in North America, allowing it to be a low-cost manufacturer and scale up to $500 million in revenue with no significant additional capex. Kits is built for the consumers of today, with its digital presence benefiting from millennials’ preference to shop online.

Oct 2, 2024 | databricks.com | Linqing Liu |Matthew Hayes |Ritendra Datta |Matei Zaharia

IntroductionApplying Large Language Models (LLMs) for code generation is becoming increasingly prevalent, as it helps you code faster and smarter. A primary concern with LLM-generated code is its correctness. Most open-source coding benchmarks are designed to evaluate general coding skills. But, in enterprise environments, the LLMs must be capable not only of general programming but also of utilizing domain-specific libraries and tools, such as MLflow and Spark SQL.

Nov 21, 2023 | databricks.com | Matthew Hayes |Hongyi Zhang |Tao Feng |Zaheera Valani

We recently announced our AI-generated documentation feature, which uses large language models (LLMs) to automatically generate documentation for tables and columns in Unity Catalog. We have been humbled by the reception of this feature among our customers. Today, more than 80% of the table metadata updates on Databricks are AI-assisted.

Oct 28, 2023 | mdpi.com | Matthew Hayes

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.

Sep 13, 2023 | nature.com | Sebastien Tremblay |Sébastien Tremblay |Ilyas Singeç |Clifford J. Woolf |Matthew Hayes |F. Christian Bennett | +4 more

AbstractWith concurrent global epidemics of chronic pain and opioid use disorders, there is a critical need to identify, target and manipulate specific cell populations expressing the mu-opioid receptor (MOR). However, available tools and transgenic models for gaining long-term genetic access to MOR+ neural cell types and circuits involved in modulating pain, analgesia and addiction across species are limited.